Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jan 7;126(7):1460–1469. doi: 10.1002/cncr.32695

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Predictive values according to prevalence based on results from matched blood samples for methylated BCAT1/IKZF1 ctDNA and CEA (n = 131). The expected range for the prevalence of recurrence is 0.1 to 0.3.5 The thresholds are 5 ng/mL for CEA and 12.8 pg per sample for ctDNA. BCAT1 indicates branched‐chain amino acid transaminase 1; CEA, carcinoembryonic antigen; ctDNA, circulating tumor DNA; IKZF1, Ikaros family zinc‐finger 1 protein; NPV, negative predictive value; PPV, positive predictive value.